mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |